GTP Bioways will attend the PEGS (Protein Engineering & Cell Therapy Summit) 2023, an event being held on Nov 14-16 in Lisbon. Séverine Hountondji, Head of Business Development and Marketing, is coming with Amira Mastouri, Business Development manager and Hervé Ginisty, CSO at GTP bioways. They will host a booth and engage in one-to-one discussions throughout the summit.
Being the largest protein & antibody engineering event in Europe, the event will bring together experts from companies (big pharmas, SME and Startups), academic laboratories as well as leading bioproduction professionals with the aim to discuss how to accelerate the development of therapeutic drugs such as mAbs, proteins, and other innovative therapies up to commercial manufacturing.
Case Studies About Innovative Recombinant Protein Vaccines of the VRI/Linkinvax Dendritic Cell-Targeting Platform
The conference will be held by Thierry Menguy, Head of CMC projects at LinkinVax and Yann Desfougères, Project Design Manager at GTP Bioways. The focus will be on case studies of innovative recombinant protein vaccines using the Dendritic Cell-Targeting Platform inherited from VRI/INSERM and the role of GTP bioways in large-scale productions.
Our team will be pleased to introduce you to our continuum of services for the manufacturing of biologics. We can also discuss your needs in cell line development, process development, GMP manufacturing, and aseptic fill and finish.
PEGS is a great opportunity to meet directly and exchange about how our end-to-end CDMO services can bring your innovative therapy one step further
Contact our team to have more information or to schedule a meeting.
